MaxCyte Files Definitive Proxy Statement for 2025 Shareholder Meeting
Ticker: MXCT · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1287098
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
MaxCyte's proxy statement is out - time to vote on directors & auditors!
AI Summary
MaxCyte, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting of stockholders. The filing outlines the proposals to be voted on, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company is seeking shareholder approval for key corporate governance matters.
Why It Matters
This filing is crucial for shareholders as it details the agenda for the upcoming annual meeting, including director elections and other important corporate decisions, allowing them to make informed voting choices.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing upcoming shareholder votes, not an event that inherently introduces new financial risk.
Key Players & Entities
- MAXCYTE, INC. (company) — Registrant
- 0001104659-25-040269.txt (document) — Filing document identifier
- 20250428 (date) — Filing date
- 20250618 (date) — Period of report
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the definitive proxy statement for MaxCyte, Inc.'s annual meeting, detailing the proposals to be voted upon.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on April 28, 2025.
What is the reporting period for this filing?
The conformed period of report for this filing is June 18, 2025.
What are the main topics typically covered in a DEF 14A filing like this one?
DEF 14A filings typically cover the election of directors, executive compensation, ratification of auditors, and other shareholder proposals.
Where is MaxCyte, Inc. headquartered?
MaxCyte, Inc. is headquartered at 9713 Key West Avenue, Suite 400, Rockville, MD 20850.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding MAXCYTE, INC. (MXCT).